Synthetic Biologics reports larger loss

Synthetic Biologics Inc., of Rockville, which develops and commercializes medicines for the treatment of serious infectious diseases, reported its first-quarter net loss totaled $2.2 million, or 5 cents per diluted share, compared with a net loss of $1.2 million, or 4 cents per diluted share, for the year-ago period.

Leave a Reply

Your email address will not be published. Required fields are marked *